MedTrace Logo

Bone Marrow-Derived Stem Cell Transfer in Acute Myocardial Infarctions

NCT00264316 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2013-01-17

No results posted yet for this study

Summary

The benefit of reperfusion therapies for ST-elevation acute myocardial infarction (STEMI) is limited by postinfarction left ventricular (LV) dysfunction.The purpose of this study is to determine whether intracoronary transfer of bone marrow cells will augment left ventricular function recovery of the heart.

Conditions

Interventions

PROCEDURE

bone marrow-derived stem cell transfer

Sponsors & Collaborators

  • Universitaire Ziekenhuizen KU Leuven

    lead OTHER

Principal Investigators

  • Stefan Janssens, MD, PhD · Department of Cardiology, University Hospital Gasthuisberg, Leuven, Belgium

  • Frans Van de Werf, MD, PhD · Department of Cardiology, University Hospital Gasthuisberg, Leuven, Belgium

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-05-31
Completion
2005-12-31

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00264316 on ClinicalTrials.gov